• Pangaea, Microsoft Collaboration, First-in-Class Monoclonal Antibody for Cancer, New LLM Tech

    Clinical Research News | Pangaea Data announces a collaboration with Microsoft; Ipsen acquires ImCheck Therapeutics; Flatiron Health released first-of-their-kind advances in LLM-extracted progression data and other uses; and more.

    Oct 29, 2025

  • Follow the Money: Best-in-Class Weight Loss Drug Trial, Novel eClinical Platform, Rheumatoid Arthritis, Other Diseases Treatments

    Clinical Research News | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Almac Group plans Almac Trial Coordinator, a first-in-class interoperable clinical trial technology platform; Elvara advances their upcoming phase 2 clinical trial of its lead candidate ELV001; and more.

    Oct 28, 2025

  • GenAI Agents and Regulatory Compliance: Streamlining Unstructured Data Extraction Gets a Lift from GenAI Agentic Frameworks

    Clinical Research News | Imagine that you’re a life sciences researcher tasked with answering a regulatory request that involves extracting meaningful data from over 200 clinical trial reports from various sources. You’re looking for patient demographics, study outcomes, adverse events, and dosage information. For decades, the industry has relied on manual effort, but GenAI agents enable far better unstructured data extraction.

    Oct 24, 2025

  • Europe's Clinical Trial Crisis: Industry Leaders Call for Urgent Action at SCOPE Europe

    Clinical Research News | European clinical research is at a critical crossroads, industry leaders warned last week at SCOPE Europe. Regulatory fragmentation, site readiness challenges, and prolonged approval timelines are driving sponsors to more competitive markets in Asia and the United States.

    Oct 22, 2025

  • ‘Simple’ NLP Tool Streamlines Metastatic Cancer Research

    Clinical Research News | Researchers at the Medical University of South Carolina (MUSC) are using a “super-simple” natural language processing (NLP) tool to streamline clinical research for metastatic brain cancer, a field where rapid advances in therapy are outpacing traditional methods of data analysis.

    Oct 21, 2025

  • The Scope of Things: Tackling the Deadlocks in Patient Recruitment

    Clinical Research News | Clinical trial recruitment has long been a hurdle in medical research, and despite decades of discussion, the obstacles are still standing, particularly in adapting marketing strategies to today’s digital world. On the latest episode of The Scope of Things, host Deborah Borfitz spoke with Christine Senn, senior vice president of site sponsor innovation at Advarra, about the challenges sites and sponsors face and offered some practical tactics for solving them.

    Oct 17, 2025

  • The Scope of Things: Tackling the Deadlocks in Patient Recruitment

    Clinical Research News | Clinical trial recruitment has long been a hurdle in medical research, and despite decades of discussion, the obstacles are still standing, particularly in adapting marketing strategies to today’s digital world. On the latest episode of The Scope of Things, host Deborah Borfitz spoke with Christine Senn, senior vice president of site sponsor innovation at Advarra, about the challenges sites and sponsors face and offered some practical tactics for solving them.

    Oct 17, 2025